Sail E0 Webinar
Question
Biological E vaccine has received DGCI approval to conduct phase 2/3 trials on children. What is the name of its COVID vaccine candidate?
Options:
A .  J&J
B .  Corbevax
C .  GSK
D .  Novavax
Answer: Option B

Hyderabad-based Biological E Limited got approval from the Drug Controller General of India (DCGI) to conduct Phase 2 & 3 clinical trials for its COVID-19 vaccine Corbevax on children aged between 5 and 18 years of age with certain conditions.



Was this answer helpful ?
Next Question

Submit Solution

Your email address will not be published. Required fields are marked *

Latest Videos

Latest Test Papers